BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 6100614)

  • 1. The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.
    de Zeeuw D; Navis GJ; Donker AJ; de Jong PE
    J Hypertens Suppl; 1983 Oct; 1(1):93-7. PubMed ID: 6100614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enalapril and the kidney: renal vasodilation and natriuresis due to the inhibition of angiotensin II formation.
    Navis GJ; de Zeeuw D; de Jong PE
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S30-4. PubMed ID: 2422491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of enalaprilic acid on sodium excretion and renal hemodynamics in essential hypertension.
    Navis G; de Jong PE; Donker AJ; van der Hem GK; de Zeeuw D
    J Clin Hypertens; 1985 Sep; 1(3):228-38. PubMed ID: 3012004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enalaprilat: an intravenous substitute for oral enalapril therapy. Humoral and pharmacokinetic effects.
    Reams GP; Lal SM; Whalen JJ; Bauer JH
    J Clin Hypertens; 1986 Sep; 2(3):245-53. PubMed ID: 3023555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension.
    O'Connor DT; Mosley CA; Cervenka J; Bernstein KN
    J Hypertens Suppl; 1984 Dec; 2(2):S89-92. PubMed ID: 6100882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of enalapril monotherapy and enalapril/hydrochlorothiazide combination therapy on blood pressure, renal function, and body fluid composition.
    Reams GP; Bauer JH
    J Clin Hypertens; 1986 Mar; 2(1):55-63. PubMed ID: 3014081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition.
    Reams GP; Singh A; Logan KW; Holmes RA; Bauer JH
    J Clin Hypertens; 1987 Jun; 3(2):153-63. PubMed ID: 3039075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the new angiotensin-converting enzyme inhibitor imidapril on renal hemodynamics and function in anesthetized dogs.
    Nishiyama S; Kanno K; Yoneda H; Yano K; Yamaguchi I
    Arzneimittelforschung; 1992 Apr; 42(4):451-6. PubMed ID: 1322673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of converting enzyme inhibition on the enhanced proximal sodium reabsorption induced by chronic diuretic treatment in patients with essential hypertension.
    van Schaik BA; Geyskes GG; Dorhout Mees EJ
    Nephron; 1987; 47(3):167-72. PubMed ID: 2825050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B; Cubela R; Johnston CI
    J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of antihypertensive effect of enalapril to serum MK-422 levels and angiotensin converting enzyme inhibition.
    Johnston CI; Jackson B; McGrath B; Matthews G; Arnolda L
    J Hypertens Suppl; 1983 Oct; 1(1):71-5. PubMed ID: 6100611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal haemodynamics and function in weanling rats treated with enalapril from birth.
    Guron G
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):865-70. PubMed ID: 16173949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and renal effects of enalapril and its effects on cardiac mass.
    Dunn FG; Oigman W; Ventura HO; Messerli FH; Kobrin I; Frohlich ED
    J Hypertens Suppl; 1984 Dec; 2(2):S57-61. PubMed ID: 6100878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
    Dzau VJ
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are the renal haemodynamic and natriuretic effects of calcium antagonists and angiotensin converting inhibitors additive?
    Natov S; Hannedouche T; Schmitt F; Ikeni A; Déchaux M; Kirkisseli S; Lacour B; Grünfeld JP
    J Hypertens Suppl; 1991 Dec; 9(6):S392-3. PubMed ID: 1819003
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of enalapril on blood pressure and renal haemodynamics in essential hypertension.
    Navis GJ; de Jong PE; Donker AJ; de Zeeuw D
    Proc Eur Dial Transplant Assoc; 1983; 20():577-81. PubMed ID: 6318224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment and recovery of the clipped kidney in two kidney, one clip hypertensive rats during and after antihypertensive therapy.
    Gröne HJ; Helmchen U
    Lab Invest; 1986 Jun; 54(6):645-55. PubMed ID: 3012198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic and metabolic aspects of enalapril action.
    Lant AF; McNabb RW; Noormohamed FH
    J Hypertens Suppl; 1984 Dec; 2(2):S37-42. PubMed ID: 6100875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.